ZL006 is a potent inhibitor of nNOS/PSD-95 interaction, and inhibits NMDA receptor-mediated NO synthesis.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | eNOS ↓ ↑ | iNOS ↓ ↑ | nNOS ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1400W 2HCl |
+
eNOS, Ki: 50 μM |
++++
iNOS, Kd: <7 nM |
++
nNOS, Ki: 2 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||
L-NAME HCl |
+++
eNOS, Ki: 39 nM |
++
iNOS, Ki: 4.4 μM |
+++
nNOS, Ki: 15 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
产品名称 | AMPA receptor ↓ ↑ | GluR ↓ ↑ | mGluR5 ↓ ↑ | NMDA receptor ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Evans Blue | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
IEM-1754 |
+
GluR3, IC50: 6 μM GluR1, IC50: 6 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Latrepirdine 2HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
(-)-Huperzine A |
+++
AChE (G4 form), Ki: 7 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
CTEP |
++++
mGlu5, IC50: 2.2 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
MPEP |
++
mGluR5, IC50: 36 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Riluzole | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | ZL006 exhibits minimal cytotoxicity, with no observed growth inhibition of BCECs at concentrations ranging from 0.001 to 10 μg/mL. However, the cytotoxic effect of T7-P-LPs/ZL006 is significantly increased at a concentration of 10 μg/mL. The uptake of ZL006-loaded P-LPs and T7-P-LPs by BCECs is evident after 0.5 hours of incubation at concentrations between 100 μg/mL and 600 μg/mL[1]. ZL006 does not interfere with the interaction between nNOS-PDZ and PSD-95-PDZ, nor does it disturb the nNOS β-finger structure[2]. |
Animal study | Relative to P-LPs/ZL006 and unencapsulated ZL006, T7-P-LPs/ZL006 shows a markedly higher accumulation of the drug in brain tissue, attributed to its enhanced ability to target the brain. In contrast, both P-LPs/ZL006 and T7-P-LPs/ZL006 demonstrate a substantial reduction in drug accumulation in the liver and kidneys when compared to free ZL006[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.05mL 0.61mL 0.30mL |
15.24mL 3.05mL 1.52mL |
30.47mL 6.09mL 3.05mL |
CAS号 | 1181226-02-7 |
分子式 | C14H11Cl2NO4 |
分子量 | 328.147 |
别名 | |
运输 | 蓝冰 |
存储条件 |
粉末 Sealed in dry,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
溶解度 |
DMSO: 25 mg/mL(76.19 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |